77 reports of this reaction
2.9% of all WHITE PETROLATUM reports
#2 most reported adverse reaction
RASH is the #2 most commonly reported adverse reaction for WHITE PETROLATUM, manufactured by Aldermed Inc.. There are 77 FDA adverse event reports linking WHITE PETROLATUM to RASH. This represents approximately 2.9% of all 2,618 adverse event reports for this drug.
Patients taking WHITE PETROLATUM who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for WHITE PETROLATUM, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for WHITE PETROLATUM:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 77 FDA reports for WHITE PETROLATUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 2.9% of all adverse event reports for WHITE PETROLATUM, making it one of the most commonly reported side effect.
If you experience rash while taking WHITE PETROLATUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.